Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Queensland Health
Cantor Fitzgerald
Harvard Business School

Generated: March 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204150

« Back to Dashboard

NDA 204150 describes DESVENLAFAXINE, which is a drug marketed by Alembic Pharms Ltd, Sun Pharma Global, Teva Pharms Usa, Actavis Labs Fl, Lupin Ltd, Mylan Pharms Inc, Sandoz Inc, West-ward Pharms Int, and Zydus Pharms Usa Inc, and is included in eleven NDAs. It is available from one supplier. Additional details are available on the DESVENLAFAXINE profile page.

The generic ingredient in DESVENLAFAXINE is desvenlafaxine succinate. There are sixteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the desvenlafaxine succinate profile page.
Summary for 204150
Applicant:Alembic Pharms Ltd
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 204150
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESVENLAFAXINE desvenlafaxine TABLET, EXTENDED RELEASE;ORAL 204150 NDA Sun Pharmaceutical Industries, Inc. 63304-191 N 63304-191-90
DESVENLAFAXINE desvenlafaxine TABLET, EXTENDED RELEASE;ORAL 204150 NDA Sun Pharmaceutical Industries, Inc. 63304-191 N 63304-191-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength50MG
Approval Date:Mar 4, 2013TE:BCRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength100MG
Approval Date:Mar 4, 2013TE:BCRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Fish and Richardson
Express Scripts
Harvard Business School
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.